Firms

First Round

United States · New York, New York · Philadelphia, Pennsylvania · San Francisco, California · Oakland, California · New Orleans, Louisiana · Mountain View, California · San Francisco Bay Area

firstround.com

signal.nfx.com

goldi.ai

First Round Capital invests at angel, pre-seed and seed, often providing first outside capital before product launch or meaningful traction. The official FAQ reports an average initial investment of USD 3.5 million as accessed 2026-10-06; historical website round sizes USD100k–20m are not individual check bounds. Later rounds represent follow-on activity.

Founded: 2004
Type: Venture capital

Funds1

First Round Capital Fund X2025-09-242025-09-24—
USD500m fundraising TARGET, no final close verified, body accountgated; notSignalUSD738m/AUM.

Team

Investments

team@apexlogos.ai7 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund size and investment stages | Item | Supported amount / status | Source and date | Interpretation | | --- | --- | --- | --- | | First Round Capital Fund X | **US$500m target**, launched/raising; no final close verified | [Venture Capital Journal, “First Round Capital launches Fund X, targeting $500m”](https://www.venturecapitaljournal.com/first-round-capital-launches-fund-x-targeting-500m/), **2025-09-24** | Latest-known credible fund report found. Public headline/date and introduction were readable; article body requires account access. Does not establish capital already raised or closed. | | Initial-investment average | **US$3.5m** | [Official FAQ](https://www.firstround.com/), undated/accessed **2026-10-06** | A check-size average, not fund size or AUM. | | Historical round sizes | Website says it has invested in rounds as small as **US$100k** and as large as **US$20m** | [Official FAQ](https://www.firstround.com/), undated/accessed **2026-10-06** | This language refers to rounds; do not automatically encode as checkMin/checkMax. | The official FAQ explicitly welcomes **angel, pre-seed and seed**, including founders before launch or before meaningful traction. Verified later transactions below demonstrate **follow-on Series A, B, C and E participation**, not a broad late-stage first-check mandate. The fund size search included Fund IX, Fund X and 2026 close/new-fund queries; no credible final-close amount or successor flagship was verified. No verified current AUM amount is asserted. Signal's US$738m cannot be reconciled to the named Fund X target from the sources available. Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | First Round Capital Fund X | Undisclosed / unverified | 2025-09-24 |
team@apexlogos.ai8 hours ago
Match research 2026-10-06 / FirstRound / sha256:54c61a4355f37a74d69dc9941ea98a1aa03210f1e2fc99c20ede5767d88efa63 / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. **NeuroVigil — direct neurotechnology, conditional attribution.** NeuroVigil's iBrain is a non-invasive EEG sensor for brain-signal analysis, sleep monitoring and neurological applications, making it a direct neurotech company. [MobiHealthNews](https://www.mobihealthnews.com/news/neurovigil-lands-venture-funding-impressive-valuation), **2011-05-04**, reports an undisclosed first financing, an anonymous lead and Howard Morgan of First Round as an investor/advisor. The company's [Business Advisory Board](https://neurovigil.ai/index.php/about-us/business-advisory-board) and [Testimonials](https://neurovigil.ai/index.php/testimonials), undated/accessed **2026-10-06**, identify Morgan as an investor and Series A leader; the advisory page explicitly describes personal seed participation. They do not establish which First Round legal fund, if any, invested. A [2021 company release on BioSpace](https://www.biospace.com/dubai-on-the-brain-neurovigil-s-philip-low-assembles-dream-team-to-launch-modern-neurotechnology-industry-expands-conglomerate-in-montreal-canada?keywords=brain%2Bimplant) likewise names Howard Morgan individually. Company pages are historical/promotional and should not establish current clinical efficacy or regulatory status. Secondary databases associate First Round with NeuroVigil: the [Crunchbase financial-details page](https://www.crunchbase.com/organization/neurovigil/financial_details), undated/accessed 2026-10-06, lists it against Series B but obscures dates/amounts; the [Q4 2021 NeuroTech investment digest](https://analytics.dkv.global/neurotech-investment-digest-q4-2021.pdf), report vintage Q4 2021/accessed 2026-10-06, also lists it. Those leads warrant checking primary round documentation. **Do not encode a definitive First Round Series B participation, date or lead role from this note.** Morgan's verified personal investment is useful context but is distinct from the firm. **Dopamine Labs:** [TechCrunch, 2017-09-08](https://techcrunch.com/2017/09/08/meet-the-tech-company-that-wants-to-make-you-even-more-addicted-to-your-phone/) explicitly attributes investment to Howard Morgan personally. Correct the snapshot's firm attribution; exclude as a verified firm neurotech investment. **PeerPong:** The NeuroTech digest also lists PeerPong, but [contemporaneous paidContent reporting preserved on Techmeme](https://www.techmeme.com/100224/p41), **2010-02-24**, describes a social-search startup and a US$2.8m financing including First Round. No neural sensing/stimulation/interface technology is established. Exclude from direct neurotech; a broad industry-map taxonomy is insufficient. **Arbor:** The saved US$9m source relates to household electricity-plan optimization. Its [official seed announcement](https://www.joinarbor.com/resources/seed-announcement), undated/accessed 2026-10-06, names First Round as lead. This is consumer climate/energy software and should not be counted as a verified physical energy-system or neurotech investment merely because of the Arbor name. Distinguish similarly named energy and biotech companies. Oui Therapeutics appears in the snapshot as a mental-health/digital-therapeutics lead; direct neural-device technology and round attribution were not independently verified here, so it is not counted as direct neurotech. ## Conflicts, missing information and later Adex review 1. **Replace stale descriptive check-size claims carefully:** official US$3.5m average supersedes the undated US$500k typical figure. Website round-size bounds are not necessarily individual check bounds. Snapshot follow-on ratios and totals lack dates and should be removed or explicitly dated rather than presented as current. 2. **Fund X:** record US$500m as a **2025 target**, with VCJ publication date and access caveat. Obtain official fundraising/closing documentation before labeling closed. Signal US$738m is unresolved; do not substitute it as AUM or Fund X size. 3. **Dyna source/amount mismatch:** snapshot participation 55487/round 24206 carries US$120m while citing the US$23.5m seed release. Verify IDs in the live record before any later correction; use separate seed and Series A sources/dates. Other Dyna rows may duplicate the Series A. 4. **64x naming:** saved company name is “64x”; official identity is **64x Bio**. The supported financing date is **2022-01-19**, not the January 29 date shown by one aggregator. 5. **NeuroVigil and Dopamine:** retain individual-versus-firm distinctions. NeuroVigil has a meaningful direct-neurotech relationship through Morgan, but no clear fund-level primary verification; Dopamine explicitly points to a personal check. 6. **Historical stage evidence:** later participation does not change the new-investment mandate from early stage. Individual contribution amounts, ownership, full current portfolio and exhaustive neurotech coverage remain unavailable. 7. **Source access:** NFX firm page rendered a directory; Todd profile was readable after retry. VCJ body is account-gated. Conclusions use official company releases where available and preserve these limitations. Research did not verify every one of the hundreds of snapshot participations; excluded/unverified leads are not evidence of absence. All linked sources were checked/accessed **2026-10-06**. Publication dates are included above when available; undated pages use the access date. This file is research for later review, not an instruction to apply changes automatically.
team@apexlogos.ai8 hours ago
Match research 2026-10-06 / FirstRound / sha256:54c61a4355f37a74d69dc9941ea98a1aa03210f1e2fc99c20ede5767d88efa63 / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # First Round - **Exact Adex ID:** `FirstRound` - **Canonical Adex URL:** https://adex.page/firms/FirstRound - **Official website:** https://www.firstround.com/ - **Research date:** 2026-10-06 - **Status:** Complete research note; no Adex/database changes made. First Round Capital is an early-stage generalist investor with verified investments in robotics, spacecraft, precision positioning and synthetic biology. Its current official mandate includes angel, pre-seed and seed. Latest-known fund evidence checked is **Fund X, a US$500 million target reported September 24, 2025**, rather than a verified closed fund. NeuroVigil is a credible direct-neurotechnology lead, but official sources establish Howard Morgan's personal investment and do not clearly establish a First Round fund commitment; retain that attribution uncertainty. ## Starting evidence: Adex and NFX Signal The exact-ID Adex snapshot `data/research/_sources/FirstRound.adex.json`, retrieved **2026-10-06T19:29:06.289Z**, identifies First Round, founded 2004, with a pre-revenue/first-outside-capital description, and cites firstround.com, Signal and Goldi. Its investorProfile checkMin, checkMax and sweetSpot are null. The description claims a typical initial investment of approximately **US$500,000** and includes undated historic follow-on-capital statistics. Those should not be carried forward as current facts: the current official FAQ gives an average initial investment of **US$3.5 million**. The snapshot includes Dyna Robotics, K2 Space, Swift Navigation, 64x, Ossium Health, Arbor, Dopamine Labs and Oui Therapeutics among many participations. These records are leads, not independent verification; many announcedAt fields are null and several rows duplicate companies/rounds or carry weak attribution. The snapshot's [NFX firm URL](https://signal.nfx.com/firms/first-round-capital) was requested directly on 2026-10-06. The browser rendering returned a broad firm directory without reliable firm-specific strategy detail. A subsequent directly readable [Todd Jackson Signal profile](https://signal.nfx.com/investors/todd-jackson), undated and accessed 2026-10-06, labels him First Round Capital partner, gives **US$100,000–US$12 million investment range**, **US$3.5 million sweet spot** and **US$738 million current fund size**, with hardware pre-seed/seed/Series A and other sector-stage tags. Investment details require sign-in. These are individual-profile/database assertions, not evidence that the firm has a US$738 million current fund or that every listed stage is its current new-investment mandate. The [official Todd Jackson page](https://www.firstround.com/team/investing/todd-jackson), undated/accessed 2026-10-06, confirms his partner identity. Signal lists several past roles as “Present,” another reason to verify freshness. ## Fund size and investment stages | Item | Supported amount / status | Source and date | Interpretation | | --- | --- | --- | --- | | First Round Capital Fund X | **US$500m target**, launched/raising; no final close verified | [Venture Capital Journal, “First Round Capital launches Fund X, targeting $500m”](https://www.venturecapitaljournal.com/first-round-capital-launches-fund-x-targeting-500m/), **2025-09-24** | Latest-known credible fund report found. Public headline/date and introduction were readable; article body requires account access. Does not establish capital already raised or closed. | | Initial-investment average | **US$3.5m** | [Official FAQ](https://www.firstround.com/), undated/accessed **2026-10-06** | A check-size average, not fund size or AUM. | | Historical round sizes | Website says it has invested in rounds as small as **US$100k** and as large as **US$20m** | [Official FAQ](https://www.firstround.com/), undated/accessed **2026-10-06** | This language refers to rounds; do not automatically encode as checkMin/checkMax. | The official FAQ explicitly welcomes **angel, pre-seed and seed**, including founders before launch or before meaningful traction. Verified later transactions below demonstrate **follow-on Series A, B, C and E participation**, not a broad late-stage first-check mandate. The fund size search included Fund IX, Fund X and 2026 close/new-fund queries; no credible final-close amount or successor flagship was verified. No verified current AUM amount is asserted. Signal's US$738m cannot be reconciled to the named Fund X target from the sources available. ## Verified previous deep-tech investments Round amounts below describe each company's aggregate financing, **not First Round's individual contribution**. Classifications are research judgments based on the technology described by primary sources. | Company | Technology and deep-tech rationale | First Round attribution, round and date | Supporting source | | --- | --- | --- | --- | | **Dyna Robotics** | Proprietary embodied-AI robot models and physical robotic arms for real-world manipulation; combines model research, hardware and deployment engineering. | **Co-led US$23.5m seed** with CRV, announced **2025-03-25**. Separately **co-led US$120m Series A** with Robostrategy and CRV, announced **2025-09-15**. Both company releases explicitly name First Round and quote partner Bill Trenchard. | [Company seed release](https://www.prnewswire.com/news-releases/dyna-robotics-raises-23-5-million-to-commercialize-embodied-ai-with-low-cost-robots-302410263.html), 2025-03-25; [company Series A release](https://www.prnewswire.com/news-releases/dyna-robotics-raises-120-million-to-advance-robotic-foundation-models-on-the-path-to-physical-artificial-general-intelligence-302556817.html), 2025-09-15. | | **K2 Space** | High-power, multi-orbit satellite platforms and spacecraft manufacturing; aerospace systems with an in-space demonstration. | **Existing investor participating in US$110m Series B**, announced **2025-02-13**; Lightspeed and Altimeter co-led. No First Round check amount disclosed. | [Company announcement](https://www.prnewswire.com/news-releases/k2-space-announces-110m-series-b-and-first-successful-in-space-demonstration-302375955.html), 2025-02-13. | | **Swift Navigation** | Centimeter-accurate satellite positioning infrastructure for autonomous vehicles, outdoor robots and precision logistics; positioning algorithms and real-world engineering. | **Existing investor participating in completed US$50m Series E**, announced **2025-07-23**; Crosslink led. | [Official Swift release](https://www.swiftnav.com/resource/press-release/swift-navigation-secures-50m-series-e-to-accelerate-global-adoption-of-centimeter-accurate-satellite-positioning), 2025-07-23. | | **64x Bio** | VectorSelect cell-line engineering for gene-therapy manufacturing; synthetic biology addressing viral-vector production constraints. | **Insider participating in closed US$55m Series A**, announced **2022-01-19**; Lifeforce led. Confirms investment at firm level. | [Official company release](https://64xbio.com/articles/64x-bio-raises-55-million-series-a-financing-to-advance-cell-line-engineering-platform-for-gene-therapy-manufacturing), 2022-01-19. | | **Ossium Health** | Bioengineering an on-demand bone-marrow bank, cryopreserved stem-cell inventory and clinical development; science-intensive cell therapy infrastructure. | **Participated in US$52m Series C**, announced **2023-07-25**; CPMG led. | [Official company release](https://ossiumhealth.com/series-c/), 2023-07-25. | These are verified examples, not an exhaustive portfolio census. Biomedical manufacturing/cell therapy is counted here as deep tech but does not automatically imply neurotech. ## Neurotech: direct lead, unresolved firm attribution and excluded adjacent cases **No verified neurotech investment found in the sources checked at unambiguous First Round fund level.** This is a bounded evidence result, not a claim that First Round has never invested in neurotechnology.
team@apexlogos.ai22 days ago
MATCH

Amy Fu First Round, vice_president	$3M$100K – $12M	New York, New York
Simon Zhou First Round, Investor	$2M$500K – $5M	San Francisco, California
Josh Kopelman First Round, partner	$2M$1M – $3M	Philadelphia, Pennsylvania
Rob Hayes First Round, partner	$1M$100K – $5M	Philadelphia, Pennsylvania
Kent Goldman First Round, partner	$800K$250K – $1M	San Francisco, California
DeVaris Brown First Round, investor	$25K$10K – $100K	Oakland, California
Mandela Schumacher-Hodge Dixon First Round, angel	$25K$10K – $50K	Oakland, California
Jon Brelig First Round, unknown	$25K$5K – $50K	San Francisco, California
Rohini Pandhi First Round, unknown	$25K$5K – $25K	San Francisco, California
Molly Fowler First Round, investor	$20K$20K – $20K	New York, New York
Evonne Johnson First Round, unknown	$10K$5K – $25K	San Francisco, California
Carson Kahn First Round, angel	$25K$5K – $500K
Jan Erik Solem First Round, unknown	$0$0 – $0
Tara Hernandez First Round, unknown	—$100K – $10M	New Orleans, Louisiana
Hayley Barna First Round, partner	—$100K – $5M	New York, New York
Joe Kahn First Round, unknown	—$1M – $50M	New York, New York
Alex Marshall First Round, investor	—$10K – $100K	San Francisco Bay Area
Todd Jackson First Round, partner	—$100K – $12M	San Francisco Bay Area · Los Angeles, California · New York, New York · Austin, Texas · Boulder, Colorado
Brett Berson First Round, partner	—$100K – $12M	San Francisco, California
James Wu First Round, investor	—$100K – $12M	San Francisco, California
Liz Wessel First Round, partner	—$100K – $12M	San Francisco, California
Youcef Es-skouri First Round, angel	—$5K – $50K	San Francisco, California
Bill Trenchard First Round, partner	—$750K – $4M	United States · San Francisco, California
An Vu First Round, Recruiter	—— – —
Anisha Gupta First Round, GTM Strategy and Ops	—— – —
Anne Loeslein First Round, Executive Assistant	—— – —
Annie Duke First Round, Special Partner, Decision Science	—— – —
Arielle Jackson First Round, Head of Brand & Product Marketing	—— – —
Bonnie Porter First Round, Recruiter	—— – —
Bruno Garcia Gonzalez First Round, Senior Software Engineer	—— – —
Caroline Min First Round, Event Coordinator	—— – —
Catherine Ferdon First Round, angel	—$5K – $100K
Chris Fralic First Round, Board Partner	—— – —
Chris Laughlin First Round, Pitch Assist Design Lead	—— – —
Cole Helms First Round, Investment Insights and Operations Lead	—— – —
Cristina Cordova First Round, partner	—$10K – $25K
Dana Fetch First Round, Senior Operations Specialist	—— – —
Dylan Terrill First Round, unknown	—$5K – $25K
Elijah Lewis First Round, Software Engineer	—— – —
Emery Rosansky First Round, VP, Founder Success & GTM	—— – —
Erica Knowlton Bennett First Round, Chief of Staff	—— – —
Hadar Dor First Round, angel	—$1K – $400K
Jason Devor First Round, Controller	—— – —
Jeff Donnon First Round, Chief Financial Officer	—— – —
Jessi Craige Shikman First Round, Editorial	—— – —
Joe Carlucci First Round, Operations Specialist	—— – —
Julianna Marchant First Round, Senior Writer	—— – —
Justin Samoy First Round, Executive Assistant & Office Manager	—— – —
Khym Brees First Round, Executive Assistant	—— – —
Lizzy Price First Round, Associate Technical Recruiter	—— – —
Locke Luhnow First Round, Associate Technical Recruiter	—— – —
Maddi Conlin First Round, Chief of Staff	—— – —
Maggie Basta First Round, Investor	—— – —
Margarette Jung First Round, Growth Marketing Director	—— – —
Mathilde Roussel First Round, GTM Enablement Manager	—— – —
Meka Asonye First Round, First Round partners	—— – —
Nate Martins First Round, Head of Content	—— – —
Nate Springer First Round, Assistant Controller	—— – —
Nick Rubin First Round, Investor	—— – —
Nyle Sykes First Round, Investor	—— – —
Rachel Ruggieri First Round, Associate Technical Recruiter	—— – —
Richard Alfonsi First Round, Board Partner	—— – —
Roy Rosin First Round, Board Partner	—— – —
Ryan Donnon First Round, Director of IT	—— – —
Shalu Attri First Round, advisor	—$10K – $100K
Sid Rajgarhia First Round, Insights and Operations	—— – —
Sofia Mendez-Nuñez First Round, Event Coordinator	—— – —
Steven Aldrich First Round, Board Partner	—— – —
Tiffany Siu First Round, Head of Talent	—— – —
Tory Macdonald First Round, Chief of Staff	—— – —
Whitney Zavilla First Round, Executive Assistant	—— – —
Will Moldow First Round, Chief of Staff	—— – —

Funds1

Team

Co-investing

Investments